November 4, 2014 5:22 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Below are the top medical laboratories & research stocks on the NYSE in terms of return on equity.The trailing-twelve-month return on equity at Laboratory Corp. of America Holdings (NYSE: LH) is 19.90%. Laboratory Corp's EPS for the same period is $5.96.The trailing-twelve-month return on equity at Charles River Laboratories International (NYSE: CRL) is 17.60%. Charles River Laboratories' operating margin for the same period is 13.70%.The trailing-twelve-month return on equity at WuXi PharmaTech (Cayman) (NYSE: WX) is 15.60%. WuXi PharmaTech's PEG ratio is 1.73The trailing-twelve-month return on equity at Agilent Technologies (NYSE: A) is 12.60%. Agilent's revenue for the same period is $6.89 billion.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.